Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
12/2008
12/11/2008CA2690101A1 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions
12/11/2008CA2689989A1 Heterocyclic compounds and uses thereof
12/11/2008CA2689985A1 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
12/11/2008CA2687912A1 Piperidine/piperazine derivatives
12/10/2008EP2000462A2 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications
12/10/2008EP1999116A2 3-aryl-substituted quinazolones, and uses thereof
12/10/2008EP1998761A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
12/10/2008EP1673085A4 C-met modulators and methods of use
12/10/2008EP1511730B1 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
12/10/2008EP1094816B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/10/2008CN101321768A 4-anilino-substituted quinazoline derivatives as tyrosine kinase inhibitors
12/10/2008CN101321740A Chemical compounds
12/10/2008CN101321739A Quinazoline derivatives used as inhibitors of erbB tyrosine kinase
12/10/2008CN101321738A Spirocyclic derivatives
12/10/2008CN101321737A Diastereomeric purification of rosuvastatin
12/10/2008CN101321731A Nicotinic acid derivatives as modulators of metabotropic glutamate receptors
12/10/2008CN101321530A Aminopyrimidines useful as kinase inhibitors
12/10/2008CN101318936A Method for preparing 5-ethyl-5-isoamyl malonyl urea
12/10/2008CN101318935A Method for preparing hydrochloric 1-(2-pyrimidine) diethylenediamine compound
12/10/2008CN100441582C Folid acid derivatives and their salts for preparing antitumor medicine
12/10/2008CN100441581C 1-[alkyl], 1-[heteroaryl]alkyl] and 1-[aryl]alkyl]-7-(pyrimidin-4-yl)-imadazo[1,2-a]pyrimidin-5(1H)-one derivatives
12/10/2008CN100441228C Use of substituted 2,4-bis (alkylamino) pyrimidines or -quinazolines as antimicrobials
12/09/2008US7462716 Statin derivatives
12/09/2008US7462628 Preventives/remedies for urinary disturbance
12/09/2008US7462625 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
12/09/2008US7462624 Purinone derivatives as HM74a agonists
12/09/2008US7462623 Quinazoline derivatives as Src tyrosine kinase inhibitors
12/09/2008US7462622 Pyrrolo[2, 3-d] pyrimidine derivatives as corticotropin releasing factor antagonists
12/09/2008US7462620 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
12/09/2008US7462619 Pyridazine, pyrimidine and pyrazine ethyne compounds
12/09/2008US7462617 Substituted acylpiperazine derivatives
12/09/2008US7462608 Non nucleoside reverse transcriptase inhibitors
12/09/2008CA2379061C Antibacterial agents
12/04/2008WO2008146914A1 Heterocyclic compound
12/04/2008WO2008145616A1 Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor)
12/04/2008WO2008145562A1 Non-nucleoside reverse transcriptase inhibitors
12/04/2008WO2008145052A1 Substituted pyrimidine ether compounds and their use
12/04/2008WO2008033749A3 Quinazoline based egfr inhibitors containing a zinc binding moiety
12/04/2008WO2008033747A3 Multi-functional small molecules as anti-proliferative agents
12/04/2008WO2008016956A3 Methods for manufacturing ary-aryl coupled polymers
12/04/2008US20080300406 Process for the Synthesis of Hmg-Coa Reductase Inhibitors
12/04/2008US20080300405 Naphthalenetetracarboxylic Aicd Derivatives and their Use as Semiconductors
12/04/2008US20080300398 Therapy for hepatitis B virus infection ; antiproliferative agents; antitumor agents; anticancer agents; HIV
12/04/2008US20080300251 Derivatives of 3-Azabicyclo[3.1.0] Hexane as Dipeptidyl Peptidase-IV Inhibitors
12/04/2008US20080300248 Quinazoline Derivatives, Preparation Methods and Uses Thereof
12/04/2008US20080300232 N-Piperidine Derivatives as Ccr3 Modulators
12/04/2008US20080300216 Dutpase Inhibitors
12/04/2008US20080299639 adduct comprising a molecule binding with a kinase; antiinflammatory agents; modulating activation state of p38 kinase protein; switch control ligands to induce or restrict conformation
12/04/2008CA2687747A1 Non-nucleoside reverse transcriptase inhibitors
12/04/2008CA2686651A1 Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor)
12/03/2008EP1997812A1 Method for production of quinazolin-4-on derivative
12/03/2008EP1997806A1 Pahrmaceutical compositions for prevention and treatment of central nervous system disorders
12/03/2008EP1996562A1 Substituted 4-amino-quinazoline derivatives as regulators of metabotropic glutamate receptors and their use for producing drugs
12/03/2008EP1996561A1 Bicyclic heterocycles, medicaments containing these compounds, their use and process for preparing them
12/03/2008EP1996560A1 Quinazolinones and their use as potassium channels activators
12/03/2008EP1996559A1 Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4
12/03/2008EP1996558A1 Heterobicyclic carboxamides as inhibitors for kinases
12/03/2008EP1996198A1 Alkylamine-substituted bicyclic aryl compounds useful as modulators of ppar
12/03/2008EP1737463B1 Pyrimidines with tie2 (tek) activity
12/03/2008EP1699767A4 Process for the preparation of pyridopyrimidones
12/03/2008EP1423388B1 2-arylamino-pyrimidines for the treatment of gsk3-related disorders
12/03/2008EP0900200B1 Pharmaceutical compositions for prevention and treatment of central nervous system disorders
12/03/2008CN101316843A Aminopyrimidines useful as kinase inhibitors
12/03/2008CN101316825A Preparation of rosuvastatin
12/03/2008CN101314594A Preparation method for 2-hydroxyl-5-fluorine pyrimidine
12/03/2008CN100439369C Purine compounds and use thereof as cannabinoid receptor ligands
12/03/2008CN100439344C 4-anilino quinazoline derivatives as antiproliferative agents
12/03/2008CN100439343C 2-alkylsulfide-5-alkyl-6-(1-cyano aromethyl) substituted uracil kind compound, its preparation method and use
12/03/2008CN100439342C Polymorphic forms of a known antihyperlipemic agent
12/03/2008CN100439332C Novel thiourea derivatives and the pharmaceutical compositions containing thd same
12/03/2008CN100439326C Process for producing substituted aniline compound
12/02/2008US7459564 thromboembolic and/or inflammatory disorders; 4-Aminomethyl-cyclohexanecarboxylic acid (1-biphenyl-3-yl-2-phenyl-ethyl)-amide; selective inhibitors of serine protease enzymes of the coagulation cascade and/or contact activation system; improved pharmacological properties, plasma kallikrein activity
12/02/2008US7459562 Monocyclic heterocycles as kinase inhibitors
12/02/2008US7459558 Enzyme inhibitor on NO-synthase enzymes; treating STROKE, NEURODEGENERATIVE DISEASES, preventing ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS; inhibiting lipidic peroxidation
12/02/2008US7459556 Process for preparing substituted 8-azabicyclo[3.2.1]octan-3-ols
12/02/2008US7459552 Reacting N-[2,4-bis(methylthio)-6-methylpyridin-3-yl]-2-[4-(2-hydroxyethyl)piperazin-1-yl]acetamide with 5-benzyloxy-2-mercaptobenzimidazole in presence of triphenylphosphine and diethyl azodicarboxylate; acyl-coenzyme A cholesterol acyltransferase (ACAT) inhibitor
12/02/2008US7459551 Method for preparing cyclic compounds
12/02/2008US7459479 Benzylated PDE4 inhibitors
12/02/2008US7459477 Chemical intermediate for agriculture, horticulture compounds; insecticide, fungicides, miticides
12/02/2008US7459460 Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators
12/02/2008US7459459 8-(3-pentylamino)-2-methyl-3-(2-methyl-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine; corticotropin releasing factor receptor antagonist; antidepressant, anxiolytic agent; eating disorder, peptic ulcer, irritable bowl syndrome, Alzheimer's disease, drug addiction or alcoholism
12/02/2008US7459458 Polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
12/02/2008US7459455 Pyrimidine compounds
12/02/2008US7459454 Aminopyrazine derivatives and compositions
12/02/2008US7459452 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
12/02/2008CA2305548C Prostaglandin agonists and their use to treat bone disorders
11/2008
11/27/2008WO2008142550A2 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors
11/27/2008WO2008142140A2 Novel 2,3-diamino-quinazolinone derivatives and their medical use
11/27/2008WO2008141843A1 Novel sulphoximine-substituted quinazoline and quinazoline derivatives as kinase inhibitors
11/27/2008WO2008030838A3 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist biological activity
11/27/2008WO2007103233A3 Processes for synthesizing 7-alkynyl-4-aminoquinazolines and a related intermediate
11/27/2008US20080293941 Method For Production Of 1-Alkyl-3-Phenyluracils
11/27/2008US20080293940 Amide Derivative and Medicine
11/27/2008US20080293939 Quinazolinone derivatives useful as anti-hyperalgesic agents
11/27/2008US20080293751 Tetralin and indane derivatives and uses thereof
11/27/2008US20080293745 New amino-alkyl-amide derivatives as CCR3 receptor ligands
11/27/2008US20080293741 Tricyclo Substituted Amides as Glucokinase Modulators
11/27/2008US20080293730 Tricyclo Substituted Amides
11/27/2008US20080293727 Amine hydroxyalkyl sulfonamides as enzyme inhibitors; for example, N-1-(3-((3-acetylamino-4-fluoro-benzenesulfonyl)-benzyl-amino)-(1S,2 syn)-1-benzyl-2-hydroxy-propyl)-2-((quinoline-2-carbonyl)-amino)-succinamide; may be used as anti-viral agents against the HIV-1 and HIV-2 viruses
11/27/2008US20080293717 Aryl sulfonamides
1 ... 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 ... 427